{"abstract":"The Clinical Center and National Heart Lung and Blood Institute, each an institute of the National Institutes of Health, Department of Health and Human Services, are contemplating the grant of an Exclusive Patent License to practice the inventions embodied in the Patents and Patent Applications listed in the Supplementary Information section of this notice to TeamedOn International Inc., (\"TeamedOn\"), a Delaware corporation with offices in Gaithersburg, Maryland.","action":"Notice.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"National Institutes of Health","name":"National Institutes of Health","id":353,"url":"https://www.federalregister.gov/agencies/national-institutes-of-health","json_url":"https://www.federalregister.gov/api/v1/agencies/353","parent_id":221,"slug":"national-institutes-of-health"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2019/11/04/2019-23993.html","cfr_references":[],"citation":"84 FR 59394","comment_url":null,"comments_close_on":"2019-11-19","correction_of":null,"corrections":[],"dates":"Only written comments and/or complete applications for a license which are received by the National Cancer Institute's Technology Transfer Center on or before November 19, 2019 will be considered.","disposition_notes":null,"docket_ids":[],"dockets":[],"document_number":"2019-23993","effective_on":null,"end_page":59394,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2019/11/04/2019-23993.xml","html_url":"https://www.federalregister.gov/documents/2019/11/04/2019-23993/prospective-grant-of-an-exclusive-patent-license-for-ointments-for-the-topical-administration-to","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2019-23993?publication_date=2019-11-04","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2019-11-04/2019-23993/mods.xml","not_received_for_publication":null,"page_length":1,"page_views":{"count":288,"last_updated":"2026-07-26 20:15:03 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2019-11-04/pdf/2019-23993.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2019-23993.pdf?1572612318","publication_date":"2019-11-04","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2019/11/04/2019-23993.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"checked_regulationsdotgov_at":"2023-02-28T18:58:36Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":59394,"subtype":null,"title":"Prospective Grant of an Exclusive Patent License for: Ointments for the Topical Administration To Treat Neuropathic and/or Ischemic Skin Ulcers in Humans","toc_doc":"Ointments for the Topical Administration to Treat Neuropathic and/or Ischemic Skin Ulcers in Humans","toc_subject":"Prospective Grant of an Exclusive Patent License:\n","topics":[],"type":"Notice","volume":84}